High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia

European Journal of Haematology

Volumn 91, Issue 3, 2013, Pages 201-208

  Tokunaga, Kenji ^a   Yamaguchi, Shunichiro ^a   Iwanaga, Eisaku ^a   Nanri, Tomoko ^a   Shimomura, Taizo ^b   Suzushima, Hitoshi ^b   Mitsuya, Hiroaki ^a   Asou, Norio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Kumamoto Shinto General Hospital   (Japan)

Author keywords

Adult; B cell acute lymphoblastic leukemia; IKZF1

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; B CELL ACUTE LYMPHOBLASTIC LEUKEMIA; CONTROLLED STUDY; EXON; FEMALE; FUSION GENE; GENE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IKZF1 GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PHILADELPHIA CHROMOSOME POSITIVE CELL; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLICING DEFECT;

ADULT; B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA; IKZF1;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; GENES, DOMINANT; HUMANS; IKAROS TRANSCRIPTION FACTOR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RNA ISOFORMS; YOUNG ADULT;

EID: 84881668584     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12155     Document Type: Article

References (32)

1. Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukemia. Blood Rev 2012;26:123-35.
2. Zuo Z, Jones D, Yao H, et al. A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Mod Pathol 2010;23:1524-34.
3. Hoshino K, Asou N, Suzushima H, Osato M, Yamasaki H, Okubo T, Nishimura S, Kiyokawa T, Kawano F, Takatsuki K. TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation. Int J Hematol 1997;66:213-8.
4. Mulighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-80.
5. Georgopoulos K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2002;2:162-74.
6. Kimberly JP, Sinisa D. Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog 2011;16:3-12.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981;47:553-61.
8. INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukemia is a favorable prognostic factor. Br J Haematol 2002;117:531-40.
9. Tanimoto M, Miyawaki S, Ino T, et al. Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: the ALL-87 study of the Japan Adult Leukemia Study Group (JALSG). Int J Hematol 1998;68:421-9.
10. Ueda T, Miyawaki S, Asou N, et al. Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1 year maintenance and intensification therapy: ALL90 study of the Japan Adult Leukemia Study Group. Int J Hematol 1998;68:279-89.
11. Takeuchi J, Kyo T, Naito K, et al. Induction therapy by frequent administration of doxorubicin with four other drugs followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Leukemia 2002;16:1259-66.
12. Jinnai I, Sakura T, Tsuzuki M, et al. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int J Hematol 2010;92:490-502.
13. Towatari M, Yanada M, Usui N, et al. Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood 2004;104:3507-12.
14. Cross NCP, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1993;8:186-9.
15. Nanri T, Uike N, Kawakita T, Iwanaga E, Mitsuya H, Asou N. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation. Genes Chromosom Cancer 2010;49:237-41.
16. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukemia is characterized by the deletion of Ikaros. Nature 2008;453:110-4.
17. Iacobucci I, Storlazzi CT, Cilloni D, et al. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood 2009;114:2159-67.
18. Liu P, Lin Z, Qian S, Qiao C, Qiu H, Wu Y, Li J, Ge Z. Expression of dominant-negative Ikaros isoforms and associated genetic alterations in Chinese adult patients with leukemia. Ann Hematol 2012;91:1039-49.
19. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003;21:4642-9.
20. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007;446:758-64.
21. Moorman AV, Schwab C, Ensor HM, et al. IGH@ translocation, CRLF2 degradation, and microdeletions in adolescent and adult with acute lymphoblastic leukemia. J Clin Oncol 2012;30:3100-8.
22. Schwab CJ, Jones LR, Morrison H, Ryan SL, Yigittop H, Schouten JP, Harrison CJ. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosom Cancer 2010;49:1104-13.
23. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E, Nieborowska-Skorska M, Blasiak J, Skorski T. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004;104:3746-53.
24. Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kansner P. Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations. Leukemia 2013;27:503-7.
25. Yoshida K, Sanada M, Shiraishi Y, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011;478:64-9.
26. +ALL). Blood 2006;108:1469-77.
27. de Labarthe A, Rousselot P, Huguet-Rigal F, et al. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of GRAAPH-2003 study. Blood 2007;109:1408-13.
28. Bassan R, Rossi G, Pogliani EM, et al. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy leukemia group Protoco 09/00. J Clin Oncol 2010;28:3644-52.
29. Iacobucci I, Lonetti A, Messa F, et al. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. Blood 2008;112:3847-55.
30. Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (IKAROS) deletions in BCR-ABL-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: AGIMEMA AL WP report. J Clin Oncol 2009;27:5202-7.
31. Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood 2010;115:206-14.
32. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukemia. Br J Haematol 2009;144:147-56.